Back to News
Market Impact: 0.2

Raymond James Sets Wall Street's Highest Price Target on SpaceX Stock at $800. Here's the Math Behind the 425% Upside Call.

+1
Technology & InnovationArtificial IntelligenceCompany FundamentalsAnalyst InsightsInvestor Sentiment & Positioning
Raymond James Sets Wall Street's Highest Price Target on SpaceX Stock at $800. Here's the Math Behind the 425% Upside Call.

SpaceX’s post-IPO quiet period ended, enabling new sell-side equity research; most coverage is bullish, with Raymond James initiating at an $800 price target—~425% upside from current levels. The bull case requires Starship commercial maturity plus >99% delivery cost cuts and ~10x payload improvements, with AI-compute capacity deals (Google Cloud, Anthropic, Reflection AI) supporting a recurring revenue narrative. However, the target assumes flawless execution and frequent-launch approvals, making near-term cash-flow and execution risk material if any milestones slip.

Analysis

Fresh coverage changes the investor base more than the business model. The immediate winners are the compute and connectivity enablers: NVDA benefits if SpaceX really needs large GPU clusters, while GOOGL benefits indirectly from validating outsourced, specialized cloud capacity demand. The first-order loser set is legacy wireless and rural broadband economics; the second-order effect is that incumbents can tolerate Starlink as a niche product until it starts taking the lowest-margin, most price-sensitive subscribers, at which point churn and promo intensity could rise faster than reported subscriber losses imply. The market should focus on what has to be true over the next 1-3 months, not the long-dated TAM story. The stock will likely trade on milestone cadence — launch frequency, regulatory approvals, and evidence that the AI/data-center contracts translate into durable backlog and margin, not just headline revenue. Any slippage in Starship or launch licensing would hit the multiple quickly because the current setup already discounts a near-perfect execution path; the thesis breaks if capital intensity rises faster than disclosed recurring revenue. Contrarian view: consensus is treating strategic relevance as if it were already bankable free cash flow. That usually overpays for optionality and underprices operational bottlenecks, especially for a business that still depends on concentrated leadership and heavy capex. In our view, the cleaner expression is to own the suppliers and adjacent beneficiaries rather than chase full valuation exposure in SPCX until the company proves repeatable launch cadence and monetization discipline.